NPI: 1801855275 · SALISBURY, NC 28144 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/22/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/22/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 15,071 | $124K |
| 2019 | 17,217 | $79K |
| 2020 | 15,105 | $69K |
| 2021 | 14,605 | $98K |
| 2022 | 10,209 | $77K |
| 2023 | 2,551 | $143K |
| 2024 | 2,499 | $163K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 27,510 | 2,193 | $687K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 19,100 | 1,169 | $44K |
| J1270 | Injection, doxercalciferol, 1 mcg | 13,245 | 1,159 | $14K |
| J1756 | Injection, iron sucrose, 1 mg | 4,134 | 1,128 | $8K |
| A4657 | Syringe, with or without needle, each | 1,530 | 1,397 | $611.02 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 738 | 556 | $0.00 |
| 83550 | 1,415 | 1,308 | $0.00 | |
| 82728 | 1,451 | 1,350 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 542 | 487 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 95 | 90 | $0.00 |
| 90674 | 52 | 49 | $0.00 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 1,289 | 467 | $0.00 |
| 85048 | 1,397 | 1,270 | $0.00 | |
| 83540 | 1,443 | 1,334 | $0.00 | |
| 85041 | 1,407 | 1,271 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 245 | 75 | $0.00 |
| 83970 | 1,541 | 1,405 | $0.00 | |
| 82108 | 123 | 114 | $0.00 |